Unknown

Dataset Information

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer.


ABSTRACT:

Background

Breast cancer anti-oestrogen resistance 4 (BCAR4) was identified in a search for genes involved in anti-oestrogen resistance in breast cancer. We explored whether BCAR4 is predictive for tamoxifen resistance and prognostic for tumour aggressiveness, and studied its function.

Methods

BCAR4 mRNA levels were measured in primary breast tumours, and evaluated for association with progression-free survival (PFS) and clinical benefit in patients with oestrogen receptor (ERα)-positive tumours receiving tamoxifen as first-line monotherapy for advanced disease. In a separate cohort of patients with lymph node-negative, ERα-positive cancer, and not receiving systemic adjuvant therapy, BCAR4 levels were evaluated for association with distant metastasis-free survival (MFS). Th

SUBMITTER: Godinho MF 

PROVIDER: S-EPMC2967058 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature